90
Views
5
CrossRef citations to date
0
Altmetric
Original Research

New serum biomarker identification and analysis by mass spectrometry in cervical precancerous lesion and acute cervicitis in South China

, , , , , , , & show all
Pages 6151-6162 | Published online: 04 Jul 2019

References

  • Ferlay J, Soerjomataram I, Ervik M, et al. Cancer incidence and mortality worldwide: IARC CancerBase. Abdom Radiol (NY). 2012;42(1):124–140. doi:10.1007/s00261-016-0901-x
  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
  • Schiffman M, Castle PE. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med. 2003;127(8):930–934. doi:10.1043/1543-2165(2003)127<930:HPEAPH>2.0.CO;212873163
  • Wright TC Jr. HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95 Suppl:1S239–S246. doi:10.1016/S0020-7292(06)60039-8
  • Wilting SM, Smeets SJ, Snijders PJ, et al. Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck. BMC Med Genomics. 2009;2(1):32–43. doi:10.1186/1755-8794-2-3219486517
  • Stoler MH, Vichnin M, Ferenczy A, et al. The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials. Int J Cancer. 2011;128(6):1354–1362. doi:10.1002/ijc.2547020506504
  • Wentzensen N, Fetterman B, Castle PE, et al. p16/Ki-67 dual stain cytology for detection of cervical precancer in HPV-positive women. J Natl Cancer Inst. 2015;107(12):1–8. doi:10.1093/jnci/djv257
  • He XK, Luo XP, Mao LZ, et al. An optoelectronic cervical cancer screening system for screening cervical cancer: comparison with cervical cytology. Nan Fang Yi Ke Da Xue Xue Bao. 2010;30(10):2304–2306.20965832
  • Xin-Chun LI, Shang JB, Xiao-Mei WU, et al. MRI findings of uterine cervical cancer and value of MRI in preoperative staging. Nan Fang Yi Ke Da Xue Xue Bao. 2007;27(3):352–354.17425990
  • Ballesta AM, Torre GC, Bombardieri E, et al. Up dating on tumor markers in tissues and in biological fluids. Minerva Med. 1993;44(2):75–78.
  • Angiolo G, Stefania C, Angelo C, et al. Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Biomed Pharmacother. 2004;58(1):24–38. doi:10.1016/j.biopha.2003.11.00314739059
  • Peiyuan Y, Guowang X. Metabolomics for tumor marker discovery and identification based on chromatography-mass spectrometry. Expert Rev Mol Diagn. 2013;13(4):339–348. doi:10.1586/erm.13.2323638817
  • Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature. 2008;455(7216):1054–1056. doi:10.1038/4551054a18948945
  • Huang S, Chong N, Lewis NE, et al. Sialic acid metabolism: a key player in breast cancer metastasis revealed by metabolomics. Front Oncol. 2018:8174–8189. doi:10.3389/fonc.2018.00174
  • Yang K, Xia B, Wang W, et al. A comprehensive analysis of metabolomics and transcriptomics in cervical cancer. Sci Rep. 2017;7(1):43353–43364. doi:10.1038/srep4335328225065
  • Ye N, Liu C, Shi P. Metabolomics analysis of cervical cancer, cervical intraepithelial neoplasia and chronic cervicitis by 1H NMR spectroscopy. Eur J Gynaecol Oncol. 2015;36(2):174–180.26050356
  • Hasim A, Ali M, Mamtimin B, Ma J-Q, Li Q-Z, Abudula A. Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by 1H NMR spectroscopy. Exp Ther Med. 2012;3(6):945–951. doi:10.3892/etm.2012.50922969997
  • Liang Q, Yu Q, Wu H, Zhu YZ, Zhang AH. Metabolite fingerprint analysis of cervical cancer using LC-QTOF/MS and multivariate data analysis. Anal Methods. 2014;6(12):3937–3942. doi:10.1039/C4AY00399C
  • Ramadan Z, Jacobs D, Grigorov M, Kochhar S. Metabolic profiling using principal component analysis, discriminant partial least squares, and genetic algorithms. Talanta. 2006;68(5):1683–1691. doi:10.1016/j.talanta.2005.08.04218970515
  • Weljie AM, Jack N, Pascal M, et al. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem. 2006;78(13):4430–4442. doi:10.1021/ac060209g16808451
  • Huang S, Chong N, Lewis NE, Jia W, Xie G, Garmire LX. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis. Genome Med. 2016;8(1):34–48. doi:10.1186/s13073-016-0289-927036109
  • Singh S, Eaton JE, Murad MH, Tanaka H, Iijima H, Talwalkar JA. Accuracy of spleen stiffness measurement in detection of esophageal varices in patients with chronic liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12(6):935–945. doi:10.1016/j.cgh.2013.09.01324055985
  • Oehr P, Adolphs HD. [Significance of biological markers for the diagnosis of urinary bladder cancer]. Onkologie. 1980;3(5):238–246. doi:10.1159/0002148017005784